France biotech urges change
As the government prepares to overhaul science, the biotech industry puts its oar in
Nov 9, 2004
France needs to invest more in the life sciences and concentrate its efforts on developing two or three main biotech clusters if it is to strengthen its competitiveness, the French biotech industry will argue during consultation meetings with government officials over the next few weeks.
France Biotech, an umbrella group for Biotech firms, told
The industry's recommendations, made jointly with the pharmaceutical industry group Les Entreprises du medicament, complement 24 proposals for reforming research that were put forward by French scientists in Grenoble last week.
Philippe Pouletty, the president of France Biotech, said that the scientific community in France had begun to organize itself to lobby the government more effectively....